Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-Cell Lung Cancer
Clinical Lung Cancer - United States
doi 10.1016/j.cllc.2016.09.005
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Elsevier BV